89 related articles for article (PubMed ID: 17239123)
1. Favorable response of pediatric stem cell recipients to human protein C concentrate substitution for veno-occlusive disease.
Eber SW; Gungor T; Veldman A; Sykora K; Scherer F; Fischer D; Grigull L
Pediatr Transplant; 2007 Feb; 11(1):49-57. PubMed ID: 17239123
[TBL] [Abstract][Full Text] [Related]
2. [Hypercoagulability in patients with veno-occlusive disease after bone marrow transplantation].
Salat C; Holler E; Reinhardt B; Kolb HJ; Pihusch R; Neumeister P; Hiller E
Med Klin (Munich); 1994 May; 89(5):245-7. PubMed ID: 8052177
[TBL] [Abstract][Full Text] [Related]
3. [Changes of blood coagulative and fibrinolytic system and function of pulmonary vascular endothelium after therapy in patients with acute pulmonary thromboembolism].
Pang BS; Wang C; Lu Y; Yang YH; Xing GH; Mao YL; Huang XX; Zhai ZG
Zhonghua Yi Xue Za Zhi; 2007 Nov; 87(43):3074-8. PubMed ID: 18261355
[TBL] [Abstract][Full Text] [Related]
4. Hepatic veno-occlusive disease with severe capillary leakage after peripheral stem cell transplantation: treatment with recombinant plasminogen activator and C1-esterase inhibitor concentrate.
Heying R; Nürnberger W; Spiekerkötter U; Göbel U
Bone Marrow Transplant; 1998 May; 21(9):947-9. PubMed ID: 9613790
[TBL] [Abstract][Full Text] [Related]
5. Veno-occlusive disease in pediatric patients affected by Wilms tumor.
Cesaro S; Spiller M; Sartori MT; Alaggio R; Peruzzo M; Saggiorato G; Bisogno G
Pediatr Blood Cancer; 2011 Aug; 57(2):258-61. PubMed ID: 21246705
[TBL] [Abstract][Full Text] [Related]
6. Veno-occlusive disease of the liver after high-dose cytoreductive therapy with busulfan and melphalan for autologous blood stem cell transplantation in multiple myeloma patients.
Carreras E; Rosiñol L; Terol MJ; Alegre A; de Arriba F; García-Laraña J; Bello JL; García R; León A; Martínez R; Peñarrubia MJ; Poderós C; Ribas P; Ribera JM; San Miguel J; Bladé J; Lahuerta JJ;
Biol Blood Marrow Transplant; 2007 Dec; 13(12):1448-54. PubMed ID: 18022574
[TBL] [Abstract][Full Text] [Related]
7. PAI-1 and protein C as early markers of veno-occlusive disease in patients treated for Wilms tumor.
Cesaro S; Mauro M; Sattin G; Sartori MT; Saggiorato G; Paratella A; Tridello G; Bisogno G
Pediatr Blood Cancer; 2019 Jul; 66(7):e27695. PubMed ID: 30865371
[TBL] [Abstract][Full Text] [Related]
8. Hepatic veno-occlusive disease after tranexamic acid administration in patients undergoing allogeneic hematopoietic stem cell transplantation.
Mori T; Aisa Y; Shimizu T; Yamazaki R; Mihara A; Yajima T; Hibi T; Ikeda Y; Okamoto S
Am J Hematol; 2007 Sep; 82(9):838-9. PubMed ID: 17506069
[TBL] [Abstract][Full Text] [Related]
9. Laboratory evidence of hyperfibrinolysis in association with low plasminogen activator inhibitor type 1 activity.
Agren A; Wiman B; Schulman S
Blood Coagul Fibrinolysis; 2007 Oct; 18(7):657-60. PubMed ID: 17890953
[TBL] [Abstract][Full Text] [Related]
10. Risk-adjusted monitoring of veno-occlusive disease following Bayesian individualization of busulfan dosage for bone marrow transplantation in paediatrics.
Brice K; Valerie B; Claire G; Valerie M; Yves B; Gilles A; Nathalie B
Pharmacoepidemiol Drug Saf; 2008 Feb; 17(2):135-43. PubMed ID: 17952879
[TBL] [Abstract][Full Text] [Related]
11. Safe administration of oral BU twice daily during conditioning for stem cell transplantation in a paediatric population: a comparative study between the standard 4-dose and a 2-dose regimen.
Mellgren K; Nilsson C; Fasth A; Abrahamsson J; Winiarski J; Ringdén O; Hassan M
Bone Marrow Transplant; 2008 Apr; 41(7):621-5. PubMed ID: 18084338
[TBL] [Abstract][Full Text] [Related]
12. [Efficacy of low-dose heparin and prostaglandin E1 in the prevention of hepatic veno-occlusive disease after allogenic hematopoietic stem cell transplantation in children with beta-thalassemia major].
Sun X; Hao WG; Liu S; Xia T; Liao C
Zhongguo Dang Dai Er Ke Za Zhi; 2007 Aug; 9(4):343-6. PubMed ID: 17706036
[TBL] [Abstract][Full Text] [Related]
13. A prospective longitudinal multicenter study of coagulation in pediatric patients undergoing allogeneic stem cell transplantation.
Brandão LR; Kletzel M; Boulad F; Kurtzberg J; Maloney K; Fligman I; Sison CP; Dimichele D
Pediatr Blood Cancer; 2008 Jun; 50(6):1240-6. PubMed ID: 18273869
[TBL] [Abstract][Full Text] [Related]
14. Hepatic Veno-Occlusive Disease: A Role for Tissue Plasminogen Activator?
Partyka J; Kim J; Tate C
Cancer Control; 1994 May; 1(3):248-251. PubMed ID: 10886975
[TBL] [Abstract][Full Text] [Related]
15. Endogenous activated protein C predicts hemorrhagic transformation and mortality after tissue plasminogen activator treatment in stroke patients.
Mendioroz M; Fernández-Cadenas I; Alvarez-Sabín J; Rosell A; Quiroga D; Cuadrado E; Delgado P; Rubiera M; Ribó M; Molina C; Montaner J
Cerebrovasc Dis; 2009; 28(2):143-50. PubMed ID: 19546541
[TBL] [Abstract][Full Text] [Related]
16. Risk factors and mortality predictors of hepatic veno-occlusive disease after pediatric hematopoietic stem cell transplantation.
Cheuk DK; Wang P; Lee TL; Chiang AK; Ha SY; Lau YL; Chan GC
Bone Marrow Transplant; 2007 Nov; 40(10):935-44. PubMed ID: 17768390
[TBL] [Abstract][Full Text] [Related]
17. Reduced intensity allogeneic umbilical cord blood transplantation in children and adolescent recipients with malignant and non-malignant diseases.
Bradley MB; Satwani P; Baldinger L; Morris E; van de Ven C; Del Toro G; Garvin J; George D; Bhatia M; Roman E; Baxter-Lowe LA; Schwartz J; Qualter E; Hawks R; Wolownik K; Foley S; Militano O; Leclere J; Cheung YK; Cairo MS
Bone Marrow Transplant; 2007 Oct; 40(7):621-31. PubMed ID: 17660841
[TBL] [Abstract][Full Text] [Related]
18. Alloreactivity as therapeutic principle in the treatment of hematologic malignancies. Studies of clinical and immunologic aspects of allogeneic hematopoietic cell transplantation with nonmyeloablative conditioning.
Petersen SL
Dan Med Bull; 2007 May; 54(2):112-39. PubMed ID: 17521527
[TBL] [Abstract][Full Text] [Related]
19. Early intervention with antithrombin III therapy to prevent progression of hepatic venoocclusive disease.
Peres E; Kintzel P; Dansey R; Baynes R; Abidi M; Klein J; Ibrahim RB; Abella E
Blood Coagul Fibrinolysis; 2008 Apr; 19(3):203-7. PubMed ID: 18388499
[TBL] [Abstract][Full Text] [Related]
20. Review article: updates in the pathogenesis and therapy of hepatic sinusoidal obstruction syndrome.
Helmy A
Aliment Pharmacol Ther; 2006 Jan; 23(1):11-25. PubMed ID: 16393276
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
